ArticleBMC cancer2020

Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer.

Masashi Sawada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.